FDA
- Status: approved
The dexamethasone plus ropivacaine (The dexamethasone plus ropivacaine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.